Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting session on Expert group convenes to discuss management strategies for EGFR mutation-positive NSCLC.
The Expert Group meeting on the management of EGFR mutation-positive non-small cell lung cancer (NSCLC) convenes to address critical aspects of treatment strategies, therapeutic advancements, and patient care. Participants, including leading oncologists, researchers, and healthcare professionals, gather to discuss the latest developments in targeted therapies, molecular diagnostics, and personalized medicine for patients with EGFR mutation-positive NSCLC.
The meeting aims to foster collaboration, exchange scientific insights, and explore innovative approaches to optimize patient outcomes and quality of life. Through comprehensive discussions, evidence-based presentations, and case studies, the Expert Group endeavors to refine treatment algorithms, identify emerging challenges, and propose novel solutions to enhance the standard of care for individuals affected by EGFR mutation-positive NSCLC.
Ultimately, the collaborative efforts of the Expert Group contribute to advancing the field of oncology and improving the prognosis and management of EGFR-driven NSCLC.
Therefore, get an overall knowledge on Expert group convenes to discuss management strategies for EGFR mutation-positive NSCLC. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Alcohol Causes Cancer. We Should Be Drinking Less.
2.
A better option for mild to moderate depression?
3.
Fuzuloparib Add-On Improves Metastatic Prostate Cancer rPFS
4.
Radiation therapy can promote amphiregulin, which increases growth of metastases
5.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
1.
Artificial Intelligence for Bone Marrow Cellular Ecosystem Modeling
2.
Introducing the Corrected Calcium Calculator: A Revolutionary Tool in Medical Assessment
3.
Treating Methemoglobinemia: What You Need to Know Now!
4.
Epigenetic Signatures for Multi-Cancer Screening
5.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Nutrition During Cancer Treatment
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
3.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
4.
Clinical Excellence in Hematology
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation